Invokana (canagliflozin) is an SGLT2 inhibitor prescribed to adults with Type 2 diabetes. Patients are told that combined with exercise and diet, Invokana (or Invokamet) can lower blood sugar and glycemic control. The drug received approval from the U.S. Food and Drug Administration (FDA) in 2013. It is manufactured by Jansenn Pharmaceuticals, a subsidiary of Johnson & Johnson. Across the United States, lawsuits have been filed against these companies alleging they failed to warn patients of risks of using this dangerous drug such as kidney failure, lower limb amputations, ketoacidosis, and heart attacks. If you or a loved one used this drug and developed an unforeseen injury, call the Invokana lawyers of Nahon, Saharovich & Trotz.FDA Warnings Against Invokana
The FDA has warned that Invokana “may lead to ketoacidosis, a serious condition... that may require hospitalization.” Common symptoms of ketoacidosis include vomiting, muscle aches, headaches, and rapid breathing, among other symptoms. If left untreated, ketoacidosis can result in diabetic comas or death. In some cases, patients who took Invokana required hospitalization due to kidney failure resulting from their use of the medication.
The FDA has issued several public warnings regarding Invokana in recent years, as the Invokana attorneys at our Memphis firm are aware.
- May 2015 – The FDA first warned that Invokana and other SGLT2-inhibitors could increase one’s risk of developing diabetic ketoacidosis (DKA).
- September 2015 – The FDA warned of increased risk of bone fractures and decreased bone mineral density related to Invokana.
- May 2016 – The FDA noted that clinical trial results were showing a potential increase in leg and foot amputations related to Invokana use, primarily to the toes.
- June 2016 – This warning first addressed an increased risk of kidney injury (kidney failure, urinary tract infection, unexplained weight loss) to Invokana users. As part of the warning, healthcare professionals were instructed to consider whether a patient would be susceptible to acute kidney issues before prescribing Invokana or similar drugs.
- May 2017 – The FDA confirmed that Invokana can cause an increased risk of leg and foot amputations. The FDA ordered that updated warning labels be created and implemented.
Diabetic patients who suffered injuries related to Invokana use may be able to recover financial compensation including medical bills, lost wages, pain and suffering, loss of enjoyment of life, and emotional distress. If the victim passed away, wrongful death damages may be recovered. Each state has its own laws relating to statutes of limitation and repose, making it critical to consult an Invokana lawyer in the Memphis area as soon as possible. Failure to abide by these laws may bar you from recovering any compensation at all.Let Our Prescription Drug Lawyers Investigate Your Case
Big pharmaceutical companies rarely admit they intentionally deceived consumers or created dangerous drugs. Whenever injury claims are made against them, they tend to devote significant resources towards defending them. If you or a loved one took Invokana and suffered ketoacidosis, kidney injury, an amputated leg, foot, or toe, or another type of injury, call Nahon, Saharovich & Trotz today. Our Invokana attorneys can investigate your case and consult with experts as needed. To schedule a free consultation, call 800-529-4004 or complete our online form. We serve clients throughout Tennessee, Arkansas, Mississippi, Missouri, and Kentucky, including in Memphis, Nashville, Knoxville, Chattanooga, Jonesboro, Little Rock, Jackson, Meridian, Tupelo, Columbus, Grenada, Starkville, Oxford, Hayti, and Caruthersville. If you need a dedicated product liability attorney to fight for your legal rights, NST is the way to go.
Disclaimer: Do not stop taking a prescribed medication without first consulting with your doctor. Discontinuing a prescribed medication without your doctor's advice can result in injury or death. In addition, any drug or medical device remains approved by the United States food and drug administration, unless the product has been recalled by a government agency or through an agreement between a manufacturer and government agency.